Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.>> Learn more…
Free White Paper
ChinaBio In the News
"Pharma in China Being Held to Higher Standard, Says Greg Scott, ChinaBio"
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
Cardinal Health Buys Majority Share of Guangzhou Baiji Xinte Drug Store | November 29, 2013
BeiGene Out-Licenses Second Molecule to Merck Serono in $232 Million Deal | November 27, 2013
PW Medtech Completes $180 Million Hong Kong IPO | November 11, 2013
China’s ZDG Options Canadian Medical Devices in a Potential Blockbuster Deal | November 9, 2013
Lorem Vascular Pays $531 Million for Rights to Cytori Cell Therapy System in China | November 6, 2013
>> See all top stories...
First event iApply to present now! Deadline: April 30